|
Interferon Alfa-2a
|
|
Roferon-A (alfa-2a)
|
Interferon Alfa-2a Clinical Trials
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- A Randomized Phase II Study of Two Doses of Interferon alfa-2a (IFN alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000754 - Completed
HIV Infections
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
HIV Infections; Hepatitis C; Liver Disease
- Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000725 - Completed
Sarcoma, Kaposi; HIV Infections
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus with Standard Treatment
ClinicalTrials.gov Identifier: NCT00006164 - Active, not recruiting
Chronic Hepatitis C; Cirrhosis, Liver; Fibrosis, Liver; Hepatic Cirrhosis
- A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00001113 - Completed
Sarcoma, Kaposi; HIV Infections
- Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov Identifier: NCT00192647 - Active, not recruiting
Chronic Hepatitis C
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
ClinicalTrials.gov Identifier: NCT00000696 - Completed
HIV Infections
- A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected with Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00008463 - Completed
HIV Infections; Hepatitis C
- Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
ClinicalTrials.gov Identifier: NCT00423397 - Recruiting
Non-Melanomatous Skin Cancer
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
ClinicalTrials.gov Identifier: NCT00491179 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-naïve Dialysis Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00491244 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
ClinicalTrials.gov Identifier: NCT00107653 - Active, not recruiting
Hepatitis C
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
recurrent adult brain tumor
- Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
stage III melanoma
- Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
Stage IV Melanoma
- Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
Hepatitis
- Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
primary systemic amyloidosis
- Evaluation of the viral kinetics and pharmacokinetics of Pegasys plus Copegus and PEG-Intron plus Rebetol in patients with Chronic Hepatitis C and previously untreated with an interferon.
ClinicalTrials.gov Identifier: NCT00087607 - Completed
Hepatitis C
- Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
ClinicalTrials.gov Identifier: NCT00093093 - Active, not recruiting
Chronic Hepatitis C
- Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000687 - Completed
Sarcoma, Kaposi; HIV Infections
- Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
stage III melanoma
- Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
Stage IV Renal Cell Cancer
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
Chronic Hepatitis C
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
Stage IV Renal Cell Cancer
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
Renal Cell Carcinoma
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
Recurrent Small Cell Lung Cancer
- Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
ClinicalTrials.gov Identifier: NCT00000967 - Completed
HIV Infections
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
stage III melanoma
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- Interferon alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00027664 - Recruiting
Stage IV Renal Cell Cancer
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
ClinicalTrials.gov Identifier: NCT00134030 - Recruiting
localized osteosarcoma; metastatic osteosarcoma
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
- Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Bevacizumab With or Without Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026221 - Recruiting
Stage IV Melanoma; Recurrent Melanoma
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Interleukin-2, Interferon alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053807 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00005615 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
ClinicalTrials.gov Identifier: NCT00082719 - Recruiting
Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
- Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
- Cisplatin, Gemcitabine, Interferon alfa, and Hyperthermia in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00004063 - Recruiting
unspecified adult solid tumor, protocol specific
- Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
recurrent cervical cancer; stage IVB cervical cancer
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00049530 - Recruiting
Recurrent Melanoma; Stage IV Melanoma
- High-Dose Interferon alfa in Treating Patients With Stage II or Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003641 - Recruiting
stage II melanoma; stage III melanoma
- Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
recurrent renal cell cancer; Stage IV Renal Cell Cancer
- Pegylated Interferon-Alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
ClinicalTrials.gov Identifier: NCT00204529 - Active, not recruiting
Melanoma
- Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
ClinicalTrials.gov Identifier: NCT00028093 - Recruiting
Hepatitis C
- Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00154869 - Recruiting
Patients with dual chronic hepatitis B and C
- A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000844 - Completed
HIV Infections
- Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00015912 - Active, not recruiting
recurrent grade I follicular small cleaved cell lymphoma; recurrent grade II follicular mixed cell lymphoma
- Temozolomide and Interferon alfa in Treating Patients With Stage III or Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00027742 - Active, not recruiting
iris melanoma; extraocular extension melanoma; recurrent intraocular melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
- Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00065468 - Active, not recruiting
Carcinoma, Renal Cell; Kidney Neoplasms
- Vaccine Therapy, Interferon alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00095862 - Recruiting
recurrent breast cancer; stage IV breast cancer
- Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Allogeneic Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00055874 - Recruiting
chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Interferon alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00045422 - Active, not recruiting
Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
unspecified adult solid tumor, protocol specific
- Combination Chemotherapy Followed By Antiviral Therapy and Interferon alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov Identifier: NCT00041327 - Active, not recruiting
stage I adult T-cell leukemia/lymphoma; stage II adult T-cell leukemia/lymphoma; stage III adult T-cell leukemia/lymphoma; ...
- Sunitinib Malate Alone and in Combination With Interferon Alfa as First-Line Therapy for Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00267748 - Recruiting
Renal Cell Carcinoma
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Efficacy of Pegylated Interferon On Liver Fibrosis in Co-Infected Patient with HIV and C Hepatitis Who Failed to Active Treatment for HCV
ClinicalTrials.gov Identifier: NCT00122616 - Active, not recruiting
HIV Infections; Hepatitis C, Chronic
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00004244 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Stage IV Melanoma; Recurrent Melanoma
- Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplantation Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00016887 - Active, not recruiting
stage III mantle cell lymphoma; stage IV mantle cell lymphoma
- Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
- Interferon alfa in Treating Patients With Advanced Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003542 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- A Study of Peginterferon Alfa-2a in Combination with Ribavirin in Patients with Chronic Hepatitis C.
ClinicalTrials.gov Identifier: NCT00144469 - Completed
Chronic Hepatitis C
- Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
- Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon alfa in Treating Patients With Advanced Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006244 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Interferon alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002737 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma
- A Study of Induction Dosing With PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C.
ClinicalTrials.gov Identifier: NCT00394277 - Active, not recruiting
Hepatitis C, Chronic
- SU011248 or Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00098657 - Recruiting
recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-Infected Patients
ClinicalTrials.gov Identifier: NCT00495131 - Recruiting
Chronic Hepatitis C
- Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer
ClinicalTrials.gov Identifier: NCT00227656 - Completed
Brain and Central Nervous System Tumors; Breast Cancer
- Interferon Gamma with Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients with Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00148863 - Completed
Hepatitis C, Chronic
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
